Huiwen Luo

Huiwen Luo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2023 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
JWJianjun Wang
Jianjun Wang
YXYang Xia
Yang Xia
YCYuan Cao
Yuan Cao
XCXianfu Cai
Xianfu Cai
SJShichun Jiang
Shichun Jiang
DWDecai Wang
Decai Wang
Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is characterized by a violent cytokine storm-driven inflammation and is associated with a predisposition to severe disease. The treatment strategy for HTG-AP consists mainly of conventional symptomatic and lipid-lowering treatments. For early-stage HTG-AP, blood purification (BP) can rapidly and effectively reduce serum triglyceride and inflammatory cytokine levels, block the development of systemic inflammatory response syndrome, and improve patient outcomes. Currently, the primary modalities for BP in patients with HTG-AP include plasma exchange, hemoperfusion, and hemofiltration. When using BP to treat patients with HTG-AP, a comprehensive analysis incorporating the elevated lipid levels and severity of the patient’s condition contributes to the selection of different treatment modes. Moreover, the timing of the treatment is also imperative. Early intervention is associated with a better prognosis for patients with HTG-AP requiring lipid-lowering treatment.

18 December 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
JWJianjun Wang
Jianjun Wang
YXYang Xia
Yang Xia
YCYuan Cao
Yuan Cao
XZXintao Zeng
Xintao Zeng
HLHua Luo
Hua Luo
DWDecai Wang
Decai Wang
Background: Surgery represents the only cure for hilar cholangiocarcinoma (HC). However, laparoscopic radical resection remains technically challenging owing to the complex anatomy and reconstruction required during surgery. Therefore, reports on laparoscopic surgery (LS) for HC, especially for types III and IV, are limited. This study aimed to evaluate the safety and feasibility of laparoscopic radical surgery for Bismuth types III and IV HC.Methods: The data of 16 patients who underwent LS and 9 who underwent open surgery (OS) for Bismuth types III and IV HC at Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, between December 2017 and January 2022 were analyzed. Basic patient information, Bismuth–Corlette type, AJCC staging, postoperative complications, pathological findings, and follow-up results were evaluated.Results: Sixteen patients underwent LS and 9 underwent OS for HC. According to the preoperative imaging data, there were four cases of Bismuth type IIIa, eight of type IIIb, and four of type IV in the LS group and two of type IIIa, four of type IIIb, and three of type IV in the OS group (P>0.05). There were no significant differences in age, sex, ASA score, comorbidity, preoperative percutaneous transhepatic biliary drainage rate, history of abdominal surgery, or preoperative laboratory tests between the two groups (P>0.05). Although the mean operative time and mean intraoperative blood loss were higher in the LS group than in OS group, the differences were not statistically significant (P=0.121 and P=0.115, respectively). Four patients (25%) in the LS group and two (22.2%) in the OS group experienced postoperative complications (P>0.05). No significant differences were observed in other surgical outcomes and pathologic findings between the two groups. Regarding the tumor recurrence rate, there was no difference between the groups (P>0.05) during the follow-up period (23.9 ± 13.3 months vs. 17.8 ± 12.3 months, P=0.240).Conclusion: Laparoscopic radical resection of Bismuth types III and IV HC remains challenging, and extremely delicate surgical skills are required when performing extended hemihepatectomy followed by complex bilioenteric reconstructions. However, this procedure is generally safe and feasible for hepatobiliary surgeons with extensive laparoscopy experience.

16 July 2024 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
SLSiyu Liu
Siyu Liu
YTYujun Tong
Yujun Tong
RSRuizi Shi
Ruizi Shi
XZXintao Zeng
Xintao Zeng
HLHua Luo
Hua Luo
JWJian jun Wang
Jian jun Wang
Idiopathic mesenteric phlebosclerosis (IMP) is an extremely rare disease with an unclear pathogenesis and risk factors. The clinical manifestations of IMP are mostly non-specific, mainly consisting of digestive symptoms such as abdominal pain, bloating and diarrhea. The diagnosis of IMP mainly relies on abdominal computed tomography (CT) and colonoscopy. Pathological changes associated with IMP often involve fibrous degeneration of the venous wall, which results in the thickening of the colonic wall and longitudinal calcification of the mesenteric arteries. Currently, there is no standard treatment protocol for IMP, and nonsurgical treatment is the mainstay of most medical centers. In this study, we reported a case of a 55-year-old female patient with IMP whose main clinical presentation was recurrent abdominal pain. The patient’s initial diagnosis was considered an incomplete intestinal obstruction and received non-surgical treatments; however, the efficacy of the treatment was unsatisfactory. After completing abdominal CT and colonoscopy, we excluded common diseases of the digestive system (e.g., tumors, Crohn’s disease), and finally considered that this patient had a high likelihood of IMP. This patient eventually underwent laparoscopic enlarged right hemicolectomy due to recurrent symptoms and poor outcomes of non-surgical treatment. Postoperative pathological results confirmed the diagnosis of IMP. During the follow-up period, the patient recovered well without recurrence of IMP. Furthermore, we have reviewed the literature related to IMP and summarized the etiology, risk factors, diagnostic methods, treatment options and prognosis of IMP.

12 June 2025 in International Journal of Surgery
Verified
Journal Article
Open access
TWTao Wang
Tao Wang
HHHaiyan Hu
Haiyan Hu
CQChuan Qin
Chuan Qin
HLHuiwen Luo
Huiwen Luo
JWJian jun Wang
Jian jun Wang
An abstract is unavailable. This article is available as a PDF only.

5 June 2025 in International Journal of Surgery
Verified
Journal Article
Open access
PYPei Yang
Pei Yang
XCXianfu Cai
Xianfu Cai
XZXintao Zeng
Xintao Zeng
HLHuiwen Luo
Huiwen Luo
JWJian jun Wang
Jian jun Wang
An abstract is unavailable. This article is available as a PDF only.

5 June 2025 in International Journal of Surgery
Verified
Journal Article
Open access
PYPei Yang
Pei Yang
WHWei He
Wei He
XCXi Chen
Xi Chen
HLHuiwen Luo
Huiwen Luo
JWJian jun Wang
Jian jun Wang
An abstract is unavailable. This article is available as a PDF only.